Ligand validation:8IRB

CLA: CHLOROPHYLL A

CLA is a Ligand Of Interest in 8IRB designated by the Author

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
8IRB_CLA_b_608	97%	7%	0.069	0.982	2.01	2.72	16	30	0	0	100%	1
8IRB_CLA_b_603	94%	6%	0.078	0.975	2.03	2.94	16	29	0	1	100%	1
8IRB_CLA_C_503	93%	8%	0.081	0.978	2.05	2.59	16	25	0	1	100%	1
8IRB_CLA_C_511	92%	6%	0.076	0.968	2.05	2.9	17	30	0	1	100%	1
8IRB_CLA_b_613	92%	7%	0.081	0.973	1.99	2.85	15	29	0	1	100%	1
8IRB_CLA_c_503	92%	8%	0.085	0.977	2.07	2.64	16	25	0	1	100%	1
8IRB_CLA_a_406	92%	7%	0.085	0.977	2	2.75	14	26	0	1	100%	0.4
8IRB_CLA_B_612	92%	7%	0.08	0.971	2.05	2.82	18	27	0	1	100%	1
8IRB_CLA_B_613	92%	7%	0.086	0.976	1.98	2.77	17	31	0	1	100%	1
8IRB_CLA_B_608	92%	7%	0.087	0.977	1.98	2.9	17	34	0	0	100%	1
8IRB_CLA_A_405	91%	7%	0.092	0.978	1.9	2.85	16	30	0	0	100%	0.4
8IRB_CLA_b_611	90%	7%	0.088	0.971	2	2.82	15	27	0	1	100%	1
8IRB_CLA_A_406	90%	7%	0.09	0.973	1.96	2.81	16	29	0	0	100%	0.4
8IRB_CLA_B_604	90%	8%	0.093	0.976	2.01	2.69	18	27	0	1	100%	1
8IRB_CLA_b_607	89%	7%	0.086	0.966	1.99	2.83	18	27	0	1	100%	1
8IRB_CLA_B_607	89%	7%	0.091	0.971	1.95	2.81	18	29	0	1	100%	1
8IRB_CLA_C_502	89%	7%	0.084	0.963	1.99	2.81	17	27	0	1	100%	1
8IRB_CLA_C_506	88%	8%	0.091	0.968	2.02	2.67	16	27	0	1	100%	1
8IRB_CLA_b_610	88%	6%	0.091	0.967	2.07	2.88	16	28	0	1	100%	1
8IRB_CLA_c_511	88%	7%	0.097	0.973	2.02	2.8	16	31	0	1	100%	1
8IRB_CLA_C_504	88%	7%	0.092	0.966	1.98	2.87	16	27	0	1	100%	1
8IRB_CLA_B_615	87%	7%	0.101	0.974	2.03	2.83	16	29	0	1	100%	1
8IRB_CLA_c_504	87%	7%	0.095	0.966	2.02	2.84	15	24	0	1	100%	1
8IRB_CLA_B_605	87%	7%	0.106	0.977	1.98	2.87	16	27	0	1	100%	1
8IRB_CLA_B_614	86%	6%	0.098	0.967	2.02	2.99	17	29	0	1	100%	1
8IRB_CLA_B_603	86%	6%	0.1	0.969	2.06	2.9	18	31	0	1	100%	1
8IRB_CLA_c_506	85%	7%	0.099	0.965	2.01	2.78	16	25	0	1	100%	1
8IRB_CLA_B_602	85%	7%	0.107	0.973	2.04	2.84	16	29	0	1	100%	1
8IRB_CLA_d_401	85%	7%	0.113	0.978	1.94	2.79	17	29	0	1	100%	0.4
8IRB_CLA_c_502	85%	7%	0.103	0.967	2	2.79	16	27	0	1	100%	1
8IRB_CLA_b_615	84%	7%	0.104	0.967	1.98	2.79	16	30	0	1	100%	1
8IRB_CLA_b_614	84%	6%	0.098	0.96	2.06	2.92	15	29	0	1	100%	1
8IRB_CLA_c_510	84%	7%	0.104	0.966	2.1	2.76	16	27	0	1	100%	1
8IRB_CLA_C_505	83%	7%	0.098	0.957	2.03	2.73	15	26	0	1	100%	1
8IRB_CLA_b_612	83%	7%	0.099	0.957	2.05	2.69	16	26	0	1	100%	1
8IRB_CLA_D_702	83%	7%	0.118	0.976	1.99	2.87	16	29	0	1	100%	0.4
8IRB_CLA_b_605	82%	7%	0.112	0.969	1.95	2.95	13	29	0	1	100%	1
8IRB_CLA_A_404	82%	7%	0.119	0.975	2.02	2.77	16	32	0	1	100%	0.4
8IRB_CLA_c_505	82%	7%	0.106	0.96	2.14	2.78	16	29	0	1	100%	1
8IRB_CLA_a_405	81%	7%	0.123	0.975	1.99	2.87	15	32	0	1	100%	0.4
8IRB_CLA_C_510	80%	7%	0.108	0.957	2.11	2.8	17	28	0	1	100%	1
8IRB_CLA_c_508	80%	7%	0.11	0.959	1.99	2.82	16	26	0	1	100%	1
8IRB_CLA_C_509	79%	7%	0.103	0.95	2.13	2.69	16	28	0	1	100%	1
8IRB_CLA_a_407	79%	7%	0.11	0.956	1.94	2.81	16	27	0	0	100%	0.4
8IRB_CLA_B_610	79%	6%	0.121	0.967	2.07	2.89	18	28	0	1	100%	1
8IRB_CLA_B_611	79%	4%	0.104	0.949	2.6	3.17	17	27	0	1	100%	1
8IRB_CLA_b_604	76%	8%	0.121	0.958	2	2.7	17	26	0	1	100%	1
8IRB_CLA_c_512	75%	7%	0.119	0.953	2.13	2.76	15	29	0	1	100%	1
8IRB_CLA_c_509	75%	7%	0.123	0.955	2.12	2.67	16	25	0	1	100%	1
8IRB_CLA_C_508	74%	7%	0.124	0.953	1.99	2.72	16	25	0	1	100%	1
8IRB_CLA_b_602	73%	6%	0.129	0.957	2.05	2.95	14	31	0	1	100%	1
8IRB_CLA_C_512	72%	7%	0.132	0.957	2.09	2.69	19	26	0	1	100%	1
8IRB_CLA_A_408	70%	6%	0.128	0.945	2.02	2.91	16	33	0	1	100%	1
8IRB_CLA_D_703	68%	7%	0.132	0.944	2.08	2.73	16	29	0	1	100%	1
8IRB_CLA_b_609	65%	7%	0.146	0.949	2	2.77	16	29	0	1	100%	1
8IRB_CLA_c_507	64%	7%	0.133	0.931	2.06	2.75	16	30	0	1	100%	1
8IRB_CLA_C_507	63%	7%	0.131	0.927	2.04	2.79	17	29	0	1	100%	1
8IRB_CLA_b_606	63%	7%	0.132	0.927	1.99	2.89	16	29	0	1	100%	1
8IRB_CLA_B_609	60%	7%	0.159	0.946	2	2.78	15	27	0	1	100%	1
8IRB_CLA_C_513	60%	7%	0.143	0.928	2.04	2.8	15	29	0	1	100%	1
8IRB_CLA_B_606	59%	6%	0.138	0.921	1.96	2.96	16	29	0	1	100%	1
8IRB_CLA_B_601	56%	7%	0.138	0.908	2.08	2.77	16	26	0	1	100%	1
8IRB_CLA_a_409	54%	7%	0.17	0.934	1.99	2.92	14	29	0	0	100%	1
8IRB_CLA_C_514	50%	7%	0.145	0.896	2.07	2.79	17	28	0	1	100%	1
8IRB_CLA_b_601	48%	7%	0.153	0.897	2.13	2.74	15	28	0	1	100%	1
8IRB_CLA_d_402	48%	7%	0.151	0.893	2.05	2.84	15	29	0	1	100%	1
8IRB_CLA_c_513	43%	7%	0.177	0.899	2.07	2.72	16	28	0	1	100%	1
8IRB_CLA_b_616	40%	6%	0.174	0.884	2.02	2.91	15	27	0	1	100%	1
8IRB_CLA_c_514	38%	6%	0.184	0.888	2.13	2.82	17	28	0	1	100%	1
8IRB_CLA_B_616	37%	6%	0.193	0.89	2.01	2.92	16	26	0	1	100%	1
5GTI_CLA_a_405	100%	7%	0.036	0.982	2.11	2.77	15	30	0	1	100%	1
5V2C_CLA_B_604	99%	14%	0.049	0.986	1.64	2.25	13	20	0	1	100%	1
2D2C_CLA_O_1201	99%	10%	0.057	0.991	2.34	1.98	19	15	7	4	100%	1
7YQ7_CLA_D_401	98%	8%	0.059	0.979	2.09	2.56	19	28	0	0	100%	1
5B66_CLA_D_402	98%	11%	0.061	0.981	1.9	2.23	16	21	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.

Prepare Data

Validate Data

Deposit Data

Help and Resources

8IRB

CLA: CHLOROPHYLL A

CLA is a Ligand Of Interest in 8IRB designated by the Author